Post Profile






Link: China CRISPR-ing away

Gizmodo: “China Has Already Gene-Edited 86 People With CRISPR”. In China’s 2015 CRISPR trial, the WSJ reports, 36 patients with cancers of the kidney, lung, liver and throat had cells removed from their bodies, altered with CRISPR, and then infused back into their bodies to fight the cancer. Other Chinese trials have sought to use CRISPR to treat HIV, esophaegeal cancer, and leukemia.
read more

share

Related Posts


U.S. FDA approves AstraZeneca's immunotherapy for lung cancer

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed.

Stanford uses CRISPR to correct sickle cell, human trials planned

Health : Reuters: Health

CHICAGO (Reuters) - Scientists at Stanford University School of Medicine have used the CRISPR gene editing tool to repair the gene that causes sickle cell disease in stem cells from diseased patients, paving the way for a potential ...

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial

Health : Reuters: Health

FRANKFURT (Reuters) - Merck KGaA and Pfizer's cancer drug Bavencio could not be shown to improve survival in lung cancer patients that had previously undergone unsuccessful chemotherapy, Merck said.

First human treated with CRISPR gene-edited cells in China, report says

News : The Rundown News Blog

For the first time, a cancer patient is being treated with cells altered using a gene editing technique called CRISPR-Cas9. Continue reading ? The post First human treated with CRISPR gene-edited cells in China, report says appeared...

Lung Cancer Patient First to Undergo CRISPR Gene Editing

Hobbies / Robotics : Singularity Hub

The CRISPR-Cas9 “drag-and-drop” gene editing technique has been used in its first human trial, reports Nature. Scientists at Sichuan University in Chengdu, China began a trial last month to treat a lung cancer patient. "Earlier clin...

Comments


Copyright © 2016 Regator, LLC